These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7917 related articles for article (PubMed ID: 15023751)

  • 1. Sentinel lymph node biopsy does not change melanoma-specific survival among patients with Breslow thickness greater than four millimeters.
    Caracò C; Celentano E; Lastoria S; Botti G; Ascierto PA; Mozzillo N
    Ann Surg Oncol; 2004 Mar; 11(3 Suppl):198S-202S. PubMed ID: 15023751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node biopsy in patients with cutaneous melanoma: outcome after 3-year follow-up.
    Mozzillo N; Caracò C; Chiofalo MG; Celentano E; Lastoria S; Botti G; Ascierto PA
    Eur J Surg Oncol; 2004 May; 30(4):440-3. PubMed ID: 15063899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
    Fairbairn NG; Orfaniotis G; Butterworth M
    J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
    J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R; Bril H; van der Loo EM; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
    Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
    Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microphthalmia transcription factor in malignant melanoma predicts occult sentinel lymph node metastases and survival.
    Naffouje S; Naffouje R; Bhagwandin S; Salti GI
    Melanoma Res; 2015 Dec; 25(6):496-502. PubMed ID: 26317170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node status and survival in cutaneous malignant melanoma--sentinel lymph node biopsy impact.
    Rutkowski P; Nowecki ZI; Nasierowska-Guttmejer A; Ruka W
    Eur J Surg Oncol; 2003 Sep; 29(7):611-8. PubMed ID: 12943629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
    de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
    Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY; Tufaro AP; Manson PN
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of sentinel node biopsy status in cutaneous melanoma: a 21-years prospective study from a single institution.
    Avilés-Izquierdo JA; Nieto-Benito LM; Lázaro-Ochaita P; Escat-Cortés JL; Marquez-Rodas I; Mercader-Cidoncha E
    Clin Transl Oncol; 2020 Sep; 22(9):1611-1618. PubMed ID: 32065344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma?
    Gajdos C; Griffith KA; Wong SL; Johnson TM; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
    Cancer; 2009 Dec; 115(24):5752-60. PubMed ID: 19827151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
    Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
    Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel node biopsy status is strongly predictive of survival in cutaneous melanoma: Extended follow-up of Oxford patients from 1998 to 2014.
    Thomson DR; Rughani MG; Kuo R; Cassell OCS
    J Plast Reconstr Aesthet Surg; 2017 Oct; 70(10):1397-1403. PubMed ID: 28625757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Final trial report of sentinel-node biopsy versus nodal observation in melanoma.
    Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Puleo CA; Coventry BJ; Kashani-Sabet M; Smithers BM; Paul E; Kraybill WG; McKinnon JG; Wang HJ; Elashoff R; Faries MB;
    N Engl J Med; 2014 Feb; 370(7):599-609. PubMed ID: 24521106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
    Roka F; Kittler H; Cauzig P; Hoeller C; Hinterhuber G; Wolff K; Pehamberger H; Diem E
    Br J Cancer; 2005 Feb; 92(4):662-7. PubMed ID: 15700039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node biopsy and survival in elderly patients with cutaneous melanoma.
    Koskivuo I; Hernberg M; Vihinen P; Virolainen S; Talve L; Seppänen M; Vahlberg T; Jahkola T
    Br J Surg; 2011 Oct; 98(10):1400-7. PubMed ID: 21638276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel Lymph Node Biopsy Provides Prognostic Value in Thick Head and Neck Melanoma.
    Monroe MM; Pattisapu P; Myers JN; Kupferman ME
    Otolaryngol Head Neck Surg; 2015 Sep; 153(3):372-8. PubMed ID: 26070510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proposal for the applicability of modified Breslow (measured from the basal membrane) as a predictor of survival and sentinel lymph node outcome in patients with cutaneous melanoma.
    Asato MA; Moares Neto FA; Moraes MPT; Ocanha-Xavier JP; Takita LC; Marques MEA; Xavier-Júnior JCC
    An Bras Dermatol; 2024; 99(3):398-406. PubMed ID: 38378363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 396.